Clinical trial
Impact of TECAR Therapy on Pain and Function in Adhesive Capsulitis: A Randomized Controlled Trial
NCT06784128 is registered in ClinicalTrials.gov with Ankara City Hospital Bilkent as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of TECAR Therapy on Pain and Function in Adhesive Capsulitis: A Randomized Controlled Trial
- Lead sponsor
- Ankara City Hospital Bilkent
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 1, 2023
- Completion date
- July 20, 2024
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adhesive capsulitis